Fast-track rapid access pathways for the diagnosis of gynaecological cancers

Stage at diagnosis is one of the key factors determining survival rates of gynaecological cancers. The development of rapid access pathways is one of the measures that have been taken to improve early diagnosis in the UK. Also known as cancer pathways, these consist of standardized referral methods to specialist clinics, where patients undergo diagnostic investigations swiftly, receive the results and commence treatment within 62  days. National cancer waiting time targets exist in conjunction with these pathways.
Source: Obstetrics, Gynaecology and Reproductive Medicine - Category: OBGYN Authors: Tags: REVIEW Source Type: research